Assessing Progressive’s Valuation After New Pet Insurance Launch And Barclays Upgrade
Progressive Corporation PGR | 195.25 | +1.03% |
Why Progressive’s new pet insurance launch matters for PGR investors
Progressive (PGR) is rolling out a new in house pet insurance product with Companion Protect, while Barclays has turned more constructive on its personal lines outlook ahead of the upcoming earnings report.
Progressive’s new in house pet insurance launch and the recent analyst upgrade come at a time when the shares trade at US$206.03, with a 30 day share price return showing a 9.29% decline. The 5 year total shareholder return of 164.41% points to strong longer run compounding even as recent momentum has faded.
If this kind of product expansion has you thinking about where else growth and ownership incentives might be lining up, it could be worth scanning fast growing stocks with high insider ownership as a next step.
With the shares down 9.29% over the past month but still carrying a 5 year total return above 160%, plus a price target of US$248.98 versus a last close of US$206.03, is there really a discount here, or is the market already baking in future growth?
Most Popular Narrative: 17.3% Undervalued
The most followed narrative pegs Progressive’s fair value at $248.98 versus a last close of $206.03, and ties that gap to very specific growth, margin, and rating assumptions.
Progressive's scale, superior data analytics, and rapid pricing response mechanisms position the company to win disproportionate market share as technology-driven direct-to-consumer distribution continues to outpace traditional agents. This directly supports outperformance in net premiums written and long-term earnings growth.
For readers curious what earnings power and margin profile would need to look like for that $248.98 fair value to hold up, and which future P/E the narrative leans on, the full story connects those dots in a way the current share price does not.
Result: Fair Value of $248.98 (UNDERVALUED)
However, this hinges on Progressive holding its edge as competition intensifies, and on claim costs not rising faster than pricing for too long.
Build Your Own Progressive Narrative
If the assumptions behind this fair value do not quite fit how you see Progressive, you can stress test the same data and build your own view with Do it your way.
A great starting point for your Progressive research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
If Progressive is already on your radar, do not stop there. Broaden your watchlist with a few focused stock ideas that come straight from data driven screens.
- Zero in on quality-focused cash flow opportunities by checking out these 872 undervalued stocks based on cash flows that currently trade below their estimated cash flow based valuations.
- Ride the AI trend more deliberately by scanning these 24 AI penny stocks that tie artificial intelligence themes to listed companies you can actually own.
- Strengthen your income side by reviewing these 13 dividend stocks with yields > 3% that aim to combine yield above 3% with listed equity exposure.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
